Free Trial

Microbix Biosystems (MBX) Competitors

Microbix Biosystems logo
C$0.40 +0.03 (+8.11%)
(As of 12/20/2024 05:17 PM ET)

MBX vs. BCT, IPA, MDNA, SCYB, COM, TH, NVH, COV, ONC, and IGX

Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Theratechnologies (TH), Novoheart (NVH), Covalon Technologies (COV), Oncolytics Biotech (ONC), and IntelGenx Technologies (IGX). These companies are all part of the "biotechnology" industry.

Microbix Biosystems vs.

BriaCell Therapeutics (CVE:BCT) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership.

BriaCell Therapeutics presently has a consensus target price of C$15.00, suggesting a potential upside of 41.51%. Given BriaCell Therapeutics' higher probable upside, equities analysts clearly believe BriaCell Therapeutics is more favorable than Microbix Biosystems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BriaCell Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Microbix Biosystems
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Microbix Biosystems received 30 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. Likewise, 70.71% of users gave Microbix Biosystems an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote.

CompanyUnderperformOutperform
BriaCell TherapeuticsOutperform Votes
40
68.97%
Underperform Votes
18
31.03%
Microbix BiosystemsOutperform Votes
70
70.71%
Underperform Votes
29
29.29%

In the previous week, Microbix Biosystems had 3 more articles in the media than BriaCell Therapeutics. MarketBeat recorded 3 mentions for Microbix Biosystems and 0 mentions for BriaCell Therapeutics. Microbix Biosystems' average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.80 indicating that Microbix Biosystems is being referred to more favorably in the news media.

Company Overall Sentiment
BriaCell Therapeutics Negative
Microbix Biosystems Neutral

Microbix Biosystems has a net margin of 21.73% compared to BriaCell Therapeutics' net margin of 0.00%. Microbix Biosystems' return on equity of 20.04% beat BriaCell Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BriaCell TherapeuticsN/A N/A N/A
Microbix Biosystems 21.73%20.04%3.82%

0.4% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Microbix Biosystems has higher revenue and earnings than BriaCell Therapeutics. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19
Microbix BiosystemsC$23.36M2.34C$5.08MC$0.0410.00

Summary

Microbix Biosystems beats BriaCell Therapeutics on 14 of the 15 factors compared between the two stocks.

MBX vs. The Competition

MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$54.68MC$164.65MC$5.14BC$6.07B
Dividend Yield2.30%3.64%5.09%5.42%
P/E Ratio10.00115.5190.0526.16
Price / Sales2.3418,239.951,117.141,332.85
Price / Cash4.1312.7543.0482.30
Price / Book2.008.504.783.07
Net IncomeC$5.08M-C$20.67MC$120.31MC$295.24M
7 Day Performance14.29%-1.04%-1.92%-2.48%
1 Month Performance33.33%136.65%11.51%-0.78%
1 Year Performance14.29%137.57%30.61%34.67%

Microbix Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
Microbix Biosystems
N/AC$0.40
+8.1%
N/A+6.7%C$54.68MC$23.36M10.00N/ANews Coverage
High Trading Volume
BCT
BriaCell Therapeutics
N/AC$10.60
-3.8%
C$15.00
+41.5%
+0.0%C$168.68MN/A-28.195
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080News Coverage
Gap Down
MDNA
Medicenna Therapeutics
N/AC$1.72
-2.8%
N/A+317.1%C$131.46MN/A-4.6620
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
N/AC$2.95
-2.6%
N/AN/AC$102.19MN/A0.00N/A
TH
Theratechnologies
N/AC$2.21
+2.8%
N/A+23.8%C$101.62MC$82.57M-11.94103News Coverage
High Trading Volume
NVH
Novoheart
N/AC$0.53
+1.9%
N/A+0.0%C$99.98MC$423,500.00-13.95N/A
COV
Covalon Technologies
N/AC$3.49
+2.9%
N/A+221.9%C$95.63MC$29.20M-84.75N/A
ONC
Oncolytics Biotech
1.0543 of 5 stars
C$1.18
flat
C$3.50
+196.6%
-29.6%C$90.70MN/A-3.1129News Coverage
High Trading Volume
IGX
IntelGenx Technologies
N/AC$0.58
+1.8%
N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up

Related Companies and Tools


This page (TSE:MBX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners